Inhibitory Effects of the Dual Endothelin Receptor Blocker Bosentan on Thrombin-Activated Lung Fibroblasts Isolated from Scleroderma Patients

Galina S Bogatkevich^*, Tanjina Akter, Anna Ludwicka-Bradley and Richard M Silver

Department of Rheumatology, Medical University of South Carolina, Charleston, USA, E-mail: akter@musc.edu

^*Corresponding Author: Galina S Bogatkevich, MD, Ph.D, Assistant Professor, Division of Rheumatology, 96 Jonathan Lucas Street, Suite 912, Medical University of South Carolina, Charleston, 29425, USA, Tel: 843-792-7631, Fax: (843) 792-7121 Email: